Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2025-12-25 @ 2:35 AM
NCT ID:
NCT05648734
Eligibility Criteria:
Inclusion Criteria:
* Adult patients who have COVID-19 pneumonia confirmed either by RT-PCR or radiologically by CT scan and according to WHO severity classification are (Moderate, severe, or critical) and has received either: Corticosteroids alone.
* Corticosteroids in combination with Colchicine.
* Corticosteroids in combination with Pirfenidone.
* Corticosteroids in combination with Colchicine and Pirfenidone.
Exclusion Criteria:
* None COVID-19 pneumonia.
* Patients with previous parenchymal lung disease.
* Patients receiving anti-fibrotic or anti-inflammatory drugs due to other chronic disease.
* Patients who received anti-fibrotic and or ant inflammatory drugs for duration and or doses less than presumed or those who reported noncompliance to treatment.
* Patients with uncontrolled comorbidities.
* Patients who develop severe intolerable side effects or derangement of liver enzymes more than 5 folds.
* Pregnant ladies with COVID-19 pneumonia.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05648734
Study Brief:
Protocol Section:
NCT05648734